Status:
NOT_YET_RECRUITING
Tailoring TM-HTN Intervention for Black Patients
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Current clinic-based hypertension (HTN) management models have several limitations, resulting in episodic care that does not adequately support patients' self-care skills, and fails to achieve blood p...
Detailed Description
Telemedicine management of HTN (TM-HTN) can augment and overcome challenges by allowing more support for patients' HTN self-care skills, providing multiple home Blood Pressure values and overcoming fa...
Eligibility Criteria
Inclusion
- Subjects must be African American or Black
- experiencing socially disadvantage
- Patients with systolic Blood Pressure ≥140 mmHg on their last two clinic visits and baseline systolic BP \>130 mmHg using the mean of two research BP values measured by trained staff
- Subjects must be on stable Blood Pressure medications for the preceding 6 weeks
Exclusion
- Unable to read or speak English
- diminished ability to measure home Blood Pressure
- chronic kidney disease ≥stage 4
- persistent/chronic atrial fibrillation
- severe hypertension \>180/110 mmHg
- acute health changes in past 3 months increasing chance of Blood Pressure instability
- terminal illness
Key Trial Info
Start Date :
August 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2028
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06593119
Start Date
August 1 2026
End Date
August 1 2028
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157